Disclosures for "Post-neurosurgical CSF Pleocytosis and Hyperproteinorrachia in Brain Tumor Patients"
-
Dr. Orellana Zambrano has nothing to disclose.
-
Dr. Khan has nothing to disclose.
-
Mrs. Rohman has received personal compensation for serving as an employee of St. Jude Children's Research Hospital. An immediate family member of Mrs. Rohman has received personal compensation for serving as an employee of St. Jude Children's Research Hospital.
-
Ms. Simmons has nothing to disclose.
-
Ms. Lin has nothing to disclose.
-
Dr. Onar-Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO. The institution of Dr. Onar-Thomas has received research support from Novocure. The institution of Dr. Onar-Thomas has received research support from Treovir. The institution of Dr. Onar-Thomas has received research support from Pediatric Brain Tumor Foundation. The institution of Dr. Onar-Thomas has received research support from Pfizer.
-
Dr. Robinson has nothing to disclose.
-
Dr. Gajjar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Therapeutics.
-
Dr. Hanzlik has received publishing royalties from a publication relating to health care.